Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Bifidobacterium animalis subsp. lactis BB-12 and Increased Short-Chain Fatty Acid Production

Research synthesisLow evidenceMixed effect size4 studies · 4 beneficial · 0 neutral · 0 harmful

Across 4 studies, all reported beneficial effects of Bifidobacterium animalis subsp. lactis BB-12 on short-chain fatty acid (SCFA) production, with effect sizes ranging from small to moderate. The highest-quality evidence (a meta-analysis in older adults) found small beneficial effects on valeric and acetic acid levels. Only 1 study reported statistical significance, and no consistent dose or form data were available.

  • Studied populations: older adults (aged ≥60 years)

Caveats: Evidence base is small (only 4 studies) — conclusions should be considered preliminary. Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Many of the included studies did not report statistical significance, and effect sizes varied from small to moderate.

Generated Jul 11, 2026
5 of 5 papers
Back to top